click tracking
Swiss Life Sciences Database

Latest News in the Life Sciences Industry

GlobeNewswire

Picard Medical Announces Pricing of $5 Million Offering

05 May 2026
Related companies: 
SynCardia Systems, LLC – a Picard Medical Company Picard Angst MedTech Venture Capital Fund Picard Angst Ltd.
PR Newswire Association LLC.

SOPHiA GENETICS Reports First Quarter 2026 Results

05 May 2026
Related companies: 
SOPHiA GENETICS SA
PR Newswire Association LLC.

Basel Area Life Sciences Supercluster Welcomes New Korean Biopharmas

05 May 2026
Related companies: 
Basel Area Business & Innovation
GlobeNewswire

Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting

05 May 2026
Related companies: 
Oculis Holding AG
PR Newswire Association LLC.

BC Platforms signs Strategic Collaboration Agreement with AWS to accelerate healthcare and life sciences innovation

05 May 2026
Related companies: 
BC Platforms AG
GlobeNewswire

Santhera Publishes Agenda for its Annual General Meeting

05 May 2026
Related companies: 
Santhera Pharmaceuticals (Schweiz) AG
GlobeNewswire

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

04 May 2026
Related companies: 
CRISPR Therapeutics AG
GlobeNewswire

Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential

04 May 2026
Related companies: 
Windward Bio AG
PR Newswire Association LLC.

ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates

04 May 2026
Related companies: 
ADC Therapeutics SA
PR Newswire Association LLC.

TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE

04 May 2026
GlobeNewswire

Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting

01 May 2026
Related companies: 
Noema Pharma AG
GlobeNewswire

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026

01 May 2026
Related companies: 
Nxera Pharma Co., Ltd. Nxera Pharma UK Limited Nxera Pharma Co. Ltd, Basel
GlobeNewswire

Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

01 May 2026
Related companies: 
Oculis Holding AG
PR Newswire Association LLC.

Oberland Biotech GmbH Secures CHF 2.5 Million Seed Funding Round to Accelerate Global Expansion in Biotechnology and Food Innovation

01 May 2026
PR Newswire Association LLC.

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

01 May 2026
Related companies: 
ADC Therapeutics SA
GlobeNewswire

Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility

30 Apr 2026
GlobeNewswire

AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease

30 Apr 2026
Related companies: 
AC Immune SA
GlobeNewswire

AC Immune First Quarter 2026 Financial and Corporate Updates

30 Apr 2026
Related companies: 
AC Immune SA
GlobeNewswire

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

30 Apr 2026
Related companies: 
SynCardia Systems, LLC – a Picard Medical Company Picard Angst MedTech Venture Capital Fund Picard Angst Ltd.
GlobeNewswire

NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026

30 Apr 2026
Related companies: 
NewcelX Ltd.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20 »

Looking for more life science news?

Browse Biotechgate for global news, company information, product pipelines, licensing opportunities, management details and much more.

Latest News All News

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
22 Nov 2024
(GlobeNewswire)
Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
21 Nov 2024
(GlobeNewswire)
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months
23 Oct 2024
(GlobeNewswire)

Upcoming Events All Events

  • October 2026
    • Milan: CPHI Milan 2026
    • Basel: 26th Annual Biotech in Europe Forum
    • Yokohama: BioJapan